Combating Generics 2008: Counter-Generics Strategy, Tactics and Execution (PH105)

Protect brand revenues with a multi-tiered counter-generics strategy:

Use this report to build a counter-generics strategy that includes long-term, R&D-based lifecycle planning (such as new formulations and next-generation drugs) as well as frontline tactics (such as litigation and counter-promotion) -- and understand how companies launch authorized generics and attempt OTC switches

Explore primary data for a comprehensive look at current counter-generics defense:

* Investigate strategies, investments and results for seven brands

* Benchmark your efforts against timelines, investment levels, and past-and-future use of critical lifecycle management and counter-generics options:

o New formulation launches

o Defensive pricing changes

o Counter-promotion

o Approval for new indications

o Next-generation product launches

o Patent litigation

o Authorized generics negotiations

o Launches through generics subsidiaries

o Pediatric trials and six-month exclusivity

o OTC switching

* Compare headcounts dedicated to counter-generics preparation over the life of a brand

Published 2007

159 Pages

450+ Metrics

60+ Charts and Diagrams
Table of Contents
Price: $7,695.00 / GBP3,847.50